
The combination showed efficacy in a predominantly female, treatment-experienced, high-BMI population.

Professor and Chair of the Department of Dermatology and Professor of Internal Medicine in the Division of Rheumatic Diseases and in the Peter O'Donnell Jr. School of Public Health at UT Southwestern Medical Center in Dallas

The combination showed efficacy in a predominantly female, treatment-experienced, high-BMI population.

Merola discussed how new data from AAD 2026 suggest broader anti-inflammatory properties of GIP/GLP-1 RAs may offer benefits beyond weight loss.